How Third-Party Vendors Can Provide More Efficient GLP-1 Utilization
Many payors are facing the expense and demand associated with GLP-1s. Find out why many of them are turning to third-party vendors, such as InformedDNA, to meet those challenges.
How DNAimpact Revolutionizes Personalized Genetic Healthcare
InformedDNA’s new platform, DNAimpact™,offers employers and health plans the opportunity for a scalable, general population precision health program. Genomic risk assessment, especially for younger populations, can lead to personalized screening and surveillance protocols for common complex diseases allowing diagnosis at earlier more treatable stages. DNAimpact™ is revolutionizing the application of genomic insights to enhance patient care and improve outcomes for all, shaping the future of precision health.
Our Take: Helping Payors Harness Precision Healthcare Providers
Exciting trends in precision health are reshaping the medical landscape at both the primary and specialty care levels. Innovations and clinical management advancements are enabling more genetic insights than ever before – and that momentum will only increase in the years to come. Today, oncologists can identify targeted therapies for certain patients using only a […]
